Inventor
MATTERN CLAUDIA
CH21 patents
⚠️ This page may combine multiple inventors who share the name “MATTERN CLAUDIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
M et P Pharma AG
7 patentsUS9962394B2May 8, 2018
Controlled release delivery system for nasal applications and method of treatment
M et P Pharma AG4 citations83
US9801834B2Oct 31, 2017
Controlled release delivery system for nasal application of neurotransmitters
M et P Pharma AG3 citations72
US10898495B2Jan 26, 2021
Treatment of demyelinating diseases
M et P Pharma AG1 citations71
US10596181B2Mar 24, 2020
Treatment of demyelinating diseases
M et P Pharma AG2 citations71
US11903951B2Feb 20, 2024
Nasal pharmaceutical compositions with a porous excipient
M et P Pharma AG0 citations61
US11723911B2Aug 15, 2023
Treatment of demyelinating diseases
M et P Pharma AG0 citations60
US10729646B2Aug 4, 2020
Nasal pharmaceutical compositions for reducing the risks of exposure to air pollutants
M et P Pharma AG0 citations51
MATTERN CLAUDIA
6 patentsUS8784882B2Jul 22, 2014
Controlled release delivery system for nasal applications and method of treatment
MATTERN CLAUDIA66 citations97
US8877230B2Nov 4, 2014
Controlled release delivery system for nasal applications
MATTERN CLAUDIA16 citations92
US8784869B2Jul 22, 2014
Controlled release delivery system for nasal applications and methods of treatment
MATTERN CLAUDIA14 citations92
US8574622B2Nov 5, 2013
Controlled release delivery system for nasal applications
MATTERN CLAUDIA18 citations92
US9186320B2Nov 17, 2015
Controlled release delivery system for nasal application of neurotransmitters
MATTERN CLAUDIA10 citations83
US8609043B2Dec 17, 2013
Use of a container of an inorganic additive containing plastic material
MATTERN CLAUDIA10 citations83
ARROWDEAN LTD
3 patentsUS5756071AMay 26, 1998
Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
ARROWDEAN LTD76 citations91
US5578588ANov 26, 1996
Medicament for increasing the testosterone level
ARROWDEAN LTD17 citations74
US5622704AApr 22, 1997
Anxiolytic
ARROWDEAN LTD4 citations58